SLC7A11 and hepatocellular carcinoma: Together, the results show that SLC7A11, as a direct transcriptional target of YAP/TAZ, is upregulated in HCC and, as mRNA or protein, is a prognostic factor of HCC aggressiveness and of clinical outcome.